DRC@UCL

#Dementia Research Centre, Dept. of Neurodegenerative Disease, @UCLIoN, @UCLBrainScience, @ucl_slms, @ucl

[Alzheimer's Society @alzheimerssoc]

Hearing loss is one of the 14 modifiable risk factors for dementia, but how the two are connected remains a mystery.

Dr. Chris Hardy, the second Alzheimer’s Society Carol Jennings Fellow, is using his groundbreaking research to explore this vital link and how changes in hearing could act as an early warning sign for Alzheimer’s disease and other dementias.

By developing new, culturally inclusive tests of “brain hearing” —how the brain processes complex sounds —he aims to create tools that make early detection and diagnosis easier for everyone.

[RareDementiaSupport @RareDementia]

The world's first Rare Dementia Support Centre is under construction. Made up of five floors across two adjoining Georgian townhouses, the new space will be changing lives from 2026. Read more and see the virtual guided tour here: https://t.co/VgYFGWybEV
#DementiaActionWeek

[Keir Yong @KeirYong]

4 yr fully-funded PhD* to understand how dementia causes 'brainsight' loss in the largest imaging-genetics study (UK Biobank) & posterior cortical atrophy (visual variant Alzheimer's):
https://t.co/RpG2u9R8FR
* @EPSRC * @BrainAppeal
@drcionucl
@RareDementia
@UCLIoN
@CombineLab

[Practical Neurology @PracticalNeurol]

Involved in dementia diagnosis and unsure about genetic testing– an outline of how to approach to diagnostic testing in commonly diagnosed dementias

@drcionucl @IonSynapse @NeurologyTUH @AntoinetteOCon @chris_belder @DrNatalieRyan @jonrohrer @NayanaLahiri

[Jonathan Schott @jmschott]

In our latest *open access* @MRCLHA paper we explore the phenomenon of accelerated forgetting in the Insight 46 cohort @Brain1878 https://t.co/bUFFdcPnJL

[Jonathan Schott @jmschott]

Out today in @TheLancetNeuro — we review excess brain volume loss following amyloid immunotherapy and conclude that it is *not* related to neuronal loss. Download here:
https://t.co/di2Dqh3ToM #ARPA @chris_belder @TheLancetNeuro

[Jonathan Schott @jmschott]

I had the pleasure of joining @GabbyLogan for a dementia themed episode of The Mid•Point podcast — we discuss how to reduce your risk, new treatments, blood tests for Alzheimer’s, and more. Available, wherever you get your podcasts https://t.co/sXMRUmKDBl

[UCL News @uclnews]

📺Watch 'The Jennings vs Alzheimer's' on @BBCTwo tonight at 9pm 📺

Find out how experts, inc. Prof Sir John Hardy, Prof Nick Fox, and Dr @cathmummery @drcionucl have shed light on #AlzheimersDisease, its causes and potential cures, for #DementiaActionWeek
https://t.co/Nwn6E4EX9Q

[Jonathan Schott @jmschott]

Great to announce that teams @UCLIoN and @DementiasUK have both been awarded the Blood Biomarker Challenge. The @ucl team will test the diagnostic utility of ptau217 for Alzheimer’s in @NHS memory clinics
@alzheimerssoc @AlzResearchUK @NIHRresearch @BBCr4today @UKDRI

[The National Brain Appeal @BrainAppeal]

Great to hear Dr @cathmummery talk to @BBCFergusWalsh about new #Alzheimer's drugs lecanemab and donanemab in @BBCPanorama's Alzheimer’s: A Turning Point, and to hear patient experiences.

Watch it here ⬇️

https://t.co/C5FmIJLyO9

[UCL Brain Sciences @UCLBrainScience]

ICYMI: "For the first time, we've got drugs that show that you can alter the course of Alzheimer's disease, and that's an extraordinary thing" Dr @cathmummery @drcionucl discusses the potential impact of new #Alzheimers treatments.

📺Watch on @BBCPanorama https://t.co/fClwg3ek3W

[Jonathan Schott @jmschott]

Our paper on iatrogenic #alzheimerdisease out today @NatureMedicine Detailed summary & links below. TLDR: 5 tragic cases resulting from a very rare medical procedure stopped in 1985. No risk of person to person spread; hopefully will provide major insights into Alzheimer biology

[DRC@UCL @drcionucl]

We are pleased to have been able to contribute to this largest ever international study of PCA posterior cortical atrophy @RareDementia @KeirYong @jmschott https://t.co/UDnNtkS7ME

[UCL Brain Sciences @UCLBrainScience]

Dr @cathmummery (@UCLIoN), head of clinical trials at the @drcionucl, has been announced as the Director of a new network of #dementia trial sites across the country.

Read more ⬇️ https://t.co/N0lmralVWz

[Jonathan Schott @jmschott]

Out today and *open access* — our large international study of posterior cortical atrophy — a distinctive syndrome almost always due to Alzheimer’s @TheLancetNeuro @UCSFmac @MayoClinic @UCLIoN @UCLBrainScience @alzassociation @AlzheimerAms https://t.co/ot3jVQTU59

[Dr Anna Volkmer @volkmer_anna]

It was wonderful to welcome @SteveJamieson12 CEO of @RCSLT to observe the role of #SLT in the dementia cognitive disorders clinic today @NHNN_therapies @drcionucl - thanks for coming!!!!

[Dr Anna Volkmer @volkmer_anna]

I am so honoured to have been able to nominate @profjasonwarren of the @dementiaBBG @drcionucl @RareDementia for this @RCSLT honorary fellowship! He has always advocated 4 the needs of people with #PPA & the role of #SLT & I personally am so grateful for his ongoing mentorship.

[Jonathan Schott @jmschott]

The program for the @ARUKscientist @AlzResearchUK Clinical Conference 2023 is now confirmed. Book your place today, and join us on Friday 10th November in London https://t.co/AQ8WOrXbY4

[Jonathan Schott @jmschott]

Latest from the Insight 46 team *open access* @braincomms — normal appearing white matter is not always normal … https://t.co/dQQ40MnT9D @Sarah_naomi_1 @JBar_UK @UCLBrainScience @MRCLHA @drcionucl @ARUKscientist @alzassociation

[Jonathan Schott @jmschott]

Excellent presentation by @davecash75 showing amyloid and tau PET data from our @MRCLHA Insight 46 data led by @WillCoath and funded by @mrc @alzassociation @ARUKscientist